GlaxoSmithKline to acquire full ownership of consumer healthcare venture from Novartis for $13bn

By on    Pharma Industry News  

GlaxoSmithKline to acquire full ownership of consumer healthcare venture from Novartis for $13bn

In a major strategic shift, GlaxoSmithKline (GSK) has finalized an agreement to acquire Novartis’ 36.5% stake in their consumer healthcare joint venture for $13 billion. This move comes shortly after GSK withdrew from a $20 billion bid to purchase Pfizer’s consumer healthcare business, indicating a focused realignment of GSK’s investment towards owning 100% of its […]

Pfizer faces setback as Reckitt Benckiser and GSK withdraw from $20bn consumer health deal

By on    Pharma Industry News  

Pfizer faces setback as Reckitt Benckiser and GSK withdraw from $20bn consumer health deal

Pfizer’s $20 Billion Sale Stalls: In a significant turn of events in the pharmaceutical industry, both Reckitt Benckiser and GlaxoSmithKline (GSK) have decided to withdraw from acquisition talks with Pfizer regarding its consumer healthcare business. This decision marks a setback for Pfizer’s plans to offload this segment, valued at approximately $20 billion. Overview of Pfizer’s […]